Pityriasis rubra pilaris (type I) following administration of the BNT162b2 mRNA COVID-19 vaccine: Successful treatment with ustekinumab and acitretin.
Shirley Braga Lima GamonalNathália Couri Vieira MarquesHeitor Motta Bini PereiraAloisio Carlos Couri GamonalPublished in: Dermatologic therapy (2022)